Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Endotoxin Shock

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Endotoxin Shock in 2 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsiao, G1
Huang, HY1
Fong, TH1
Shen, MY1
Lin, CH1
Teng, CM2
Sheu, JR1
Pan, SL1
Guh, JH1
Peng, CY1
Chang, YL1
Cheng, FC1
Chang, JH1
Kuo, SC1
Lee, FY1

Other Studies

2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Endotoxin Shock

ArticleYear
Inhibitory mechanisms of YC-1 and PMC in the induction of iNOS expression by lipoteichoic acid in RAW 264.7 macrophages.
    Biochemical pharmacology, 2004, Apr-01, Volume: 67, Issue:7

    Topics: Animals; Chromans; Drug Interactions; Enzyme Activation; Gene Expression; Indazoles; Lipopolysacchar

2004
A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:5

    Topics: Animals; Blotting, Western; Cyclic GMP; Cytokines; Disease Models, Animal; DNA; Endotoxemia; Humans;

2005